When: October 21–24, 2004
Where: Marriott Hotel, Philadelphia, PA
Institute: National Institute of Allergy and Infectious Diseases (NIAID)

Participants at the largest national AIDS workers' conference, the United States Conference on AIDS (USCA), will be able to hear about the latest developments in HIV vaccine research and the importance of clinical trial participation. Speaking on those subjects will be NIAID representatives, who will network with more than 4,000 dedicated case managers, physicians, public health workers, advocates, policy makers, and other leaders in the field.

NIAID’s HIV Vaccine Communications Campaign will participate in a special full-day session sponsored by NIH. Representatives will discuss preventive HIV vaccine research and the importance of incorporating this research into larger HIV prevention strategies. In addition, members of NIAID-funded community advisory boards and constituency groups are organizing a morning session on the importance of clinical trial participation, particularly for underrepresented populations. The conference's main sponsor is the National Minority AIDS Council (NMAC), a national organization dedicated to developing leadership within communities of color to address the challenges of HIV/AIDS.

Next Steps
For information, contact Matthew Murguía at (301) 435-7164 or visit the conference Web site at http://www.nmac.org/conferences/usca2004. Registration fees range from $375–$550.